Imran Khan
Internal Medicine · Shenandoah, TXNPI 1598045791
Payments from drug & device makers
Across 133 payments — averaging $16.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$317
- Novartis$276
- AbbVie$237
- Amgen$203
- Kerecis Limited$138
- Avion Pharmaceuticals$84
- plus $903 from 29 others
What the payments were for
- Food & beverage$2,14499%
- Education$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 33 | $317 |
| Novartis | 19 | $276 |
| AbbVie | 14 | $237 |
| Amgen(2 entities) | 13 | $203 |
| Kerecis Limited | 1 | $138 |
| Avion Pharmaceuticals | 5 | $84 |
| Pfizer | 3 | $76 |
| Johnson & Johnson | 5 | $69 |
| Lilly USA, LLC | 4 | $68 |
| Abbott | 1 | $61 |
| Actelion Pharmaceuticals US, Inc. | 2 | $59 |
| Astellas Pharma US Inc | 4 | $52 |
| Optinose US, Inc. | 2 | $45 |
| Corcept Therapeutics | 2 | $45 |
| Springworks Therapeutics, Inc. | 2 | $38 |
| SK Life Science, Inc. | 2 | $34 |
| AstraZeneca | 2 | $32 |
| Sanofi-aventis U.S. LLC | 2 | $28 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Neurelis, Inc. | 1 | $22 |
| UCB, Inc. | 1 | $22 |
| GSK | 1 | $20 |
| Livanova USA, Inc. | 1 | $19 |
| Impel Pharmaceuticals Inc. | 1 | $19 |
| Life Molecular Imaging Ltd | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Medtronic | 1 | $17 |
| Insmed, Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Halozyme Inc | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Sunovion Pharmaceuticals Inc. | 1 | $14 |
| Radius Health, Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,158 in reported general payments places this provider in the 75th percentile of 7,675 internal medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 35 | $1,636 |
| Levothyroxine Sodium | 99 | $992 |
| Estradiol (Twice Weekly)Estradiol | 15 | $746 |
| Montelukast Sodium | 31 | $381 |
| Losartan Potassium | 36 | $344 |
| Tamsulosin Hcl | 21 | $272 |
| Atorvastatin Calcium | 37 | $243 |
| Metoprolol Succinate | 21 | $214 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $204 |
| Pantoprazole Sodium | 21 | $201 |
| Metformin Hcl ErMetformin Hcl | 21 | $195 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 16 | $172 |
| Zolpidem Tartrate | 19 | $161 |
| Gabapentin | 11 | $160 |
| Simvastatin | 26 | $158 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Shenandoah
- Jan BurgerHouston$47.3M
- Nitin JainHouston$33.2M
- Muhammad IrfanTomball$30.6M
- Aung NaingHouston$30.6M
- Robert BassSan Antonio$25.6M
- Preetesh JainHouston$19.5M
- Paolo StratiHouston$19.2M
- Hernan SalazarSan Antonio$18.5M
- Nicholas ShortHouston$17.6M
- Salma SaigerMesquite$16.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.